Mario Damo

Mario Damo is a finance executive with extensive experience in the pharmaceutical and consumer goods industries. Currently serving as CFO of Takeda Oncology since October 2023, Mario has held significant finance leadership roles at Biogen from October 2020 to October 2023, including VP Finance for both the US and Intercontinental Region. From September 2010 to September 2020, Mario worked at GSK in various capacities, such as VP Office of the CFO and VP Finance for Global Vaccines Commercial. Prior experience includes a decade at The Coca-Cola Company, where Mario served in several director-level positions, and earlier roles at Jardine Davies Inc., Procter & Gamble, and Sycip, Gorres and Velayo. Mario holds a BSBA in Accounting from the University of the East, earned between 1987 and 1991.